[1] |
Liu Jia, Yang Fengyu, Guo Mengya, Wu Zhuowei, Zhang Hanwen, Wang Yixuan, Chen Chunhong, Zhang Fang.
The safety and efficacy of low-dose rivaroxaban in elderly patients with renal insufficiency and non-valvular atrial fibrillation
[J]. Clinical Focus, 2025, 40(6): 509-512.
|
[2] |
Wang Xiaoxiao, Hu Yanfeng, Qi Xiufeng, Zhao Junjie.
Acute pulmonary embolism with epilepsy attack as the first clinical manifestation: A case report and literature review
[J]. Clinical Focus, 2025, 40(6): 532-536.
|
[3] |
Tang Xu, Zuo Zhuang, Yang Kai, Zhang Zhiyuan, Wang Qi, Dong Xinchun, Gou Yunjiu.
The efficacy and safety of anti-angiogenic drugs combined with chemotherapy in treating malignant pleural mesothelioma: An updated systematic review and meta-analysis
[J]. Clinical Focus, 2025, 40(4): 304-312.
|
[4] |
Zhao Shiliang, Niu Yanguo, Zhao Yanmin, Li Junqing, Hong Li, Wang Xian.
Factors influencing cognitive dysfunction after interventional surgery for intracranial aneurysms: A PSM study
[J]. Clinical Focus, 2025, 40(4): 320-324.
|
[5] |
Yue Jianghong, Wang Heng, Cai Gang, Zhang Xuanming, Peng Xi.
Efficacy and safety of sotagliflozin in the treatment of type 2 diabetes mellitus: A meta-analysis
[J]. Clinical Focus, 2024, 39(7): 581-592.
|
[6] |
Liu Lei, Li Mingwu, Wan Rong.
Diagnostic value of laboratory indexes in patients with pulmonary tuberculosis complicated by pulmonary embolism
[J]. Clinical Focus, 2024, 39(2): 134-139.
|
[7] |
Qin Qiaoling, Mo Ranghui, Chen Xinyi.
Efficacy and safety of the direct-acting anti-HCV therapy based on efavirenz-containing regimen on HIV/HCV co-infected patients
[J]. Clinical Focus, 2024, 39(10): 921-924.
|
[8] |
Li Hai, Liu Wenhu, Peng Shaopeng, Wang Fei.
Meta-analysis of the efficacy of controlled stepwise decompression versus rapid standard large bone-flap decompression on the treatment of severe craniocerebral injury
[J]. Clinical Focus, 2023, 38(9): 788-795.
|
[9] |
Wang Tengyan, He Yajun, Shu Jianchang.
Rebamipide in the treatment of nonsteroidal anti-inflammatory drug-associated intestinal disease: A meta-analysis
[J]. Clinical Focus, 2022, 37(8): 685-690.
|
[10] |
Li Shufan, Wang Yuxiu, Jiang Zhenghua.
The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation
[J]. Clinical Focus, 2022, 37(11): 985-991.
|
[11] |
Cui Lu, Li Jing, Liu Yuhong.
Primary Sjögren’s syndrome with pulmonary embolism:a case report and literature review
[J]. Clinical Focus, 2021, 36(4): 361-364.
|
[12] |
Huang Ping, Liu Hanyun, Li Yuhong.
Risk factors of lung cancer with pulmonary embolism:a meta-analysis
[J]. Clinical Focus, 2021, 36(12): 1061-1066.
|
[13] |
Ma Jincai, Ma Rongzhi, Ma Zhenzhen.
Efficacy and safety of rivaroxaban in elderly patients with nonvalvular atrial fibrillation complicated with cardiac insufficiency
[J]. Clinical Focus, 2020, 35(5): 413-416.
|
[14] |
Li Shuangping, Mao Yimin, He Xuegai.
Diagnostic value of modified Wells score in lung cancer complicated with venous thromboembolism
[J]. Clinical Focus, 2020, 35(5): 421-424.
|
[15] |
Su Yongcai, Zhang Xiaole, Huang Zhifeng, Feng Xinwu.
Clinical analysis of treatment of trigeminal lesions after right coronary artery with single stent by different methods
[J]. Clinical Focus, 2020, 35(4): 322-325.
|